Helton, David R. et al
"Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors." Journal of Pharmacology and Experimental Therapeutics
284.2
(1998):
651-660.
Web. 18 April. 2024.